A wrap-around approach to managing endometriosis
With a new medicine available for endometriosis, here's how pharmacists can screen for the ‘missed disease’ and discuss appropriate options.
ATAGI highlights progress amid resurgent diseases
ATAGI flagged worrying vaccine coverage declines and renewed disease threats, with pharmacists tipped to boost community protection.
Pharmacists go above and beyond as Victorian storm leads to weeks...
Thousands of residents continue to be left without electricity or running water after storms battered Victoria’s Dandenong Ranges recently. AP speaks to pharmacists on the ground.
Aus CVD risk: the Australian cardiovascular disease risk calculator
The 2023 Aus CVD Risk calculator and guideline provide updated evidence-based recommendations for identifying, assessing, communicating and managing CVD risk in a primary prevention setting.
How expanded scope is redefining pharmacy practice
Rapidly evolving scope of practice means that traditional community pharmacy workflows need review. What works (and what doesn’t)?
Vyvanse® (lisdexamfetamine dimesilate) for treatment of adults with ADHD
Vyvanse® (lisdexamfetamine dimesilate) for treatment of adults with ADHD: PBS listed from 1 February 20211,2













